Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
• Rapid7 (RPD) PT Raised to $14 at Canaccord
• Cogent (COGT) PT Raised to $52 at Guggenheim